TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
Go back to TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting| TG THERAP (NASDAQ: TGTX) | Delayed: 53.94 -0.46 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.40 | 52 Week High | $14.87 | |||
| Open | $54.00 | 52 Week Low | $4.90 | |||
| Day High | $55.52 | P/E | N/A | |||
| Day Low | $52.70 | EPS | $-0.67 | |||
| Volume | 3,140,095 | |||||
